During the past decade, Institute for Behavioral Medicine conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 16 clinical trials were completed, i.e. on average, 320% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institute for Behavioral Medicine" #1 sponsor was "Shire" with 5 trials, followed by "Sunovion" with 4 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 3 trials sponsored, "Curemark" with 2 trials sponsored and "Neuropharm" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institute for Behavioral Medicine" #1 collaborator was "Autism Speaks" with 2 trials as a collaborator and "Otsuka America Pharmaceutical" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Institute for Behavioral Medicine" are "Major Depressive Disorder" (5 trials), "Autistic Disorder" (4 trials), "Autism" (3 trials), "Attention Deficit Hyperactivity Disorder (ADHD)" (2 trials) and "Autism Spectrum Disorders" (2 trials). Many other conditions were trialed in "Institute for Behavioral Medicine" in a lesser frequency.

Most popular intervention types in "Institute for Behavioral Medicine" are "Drug" (26 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Aripiprazole" (3 trials), "CM-AT" (2 trials), "Fluoxetine" (2 trials) and "Lurasidone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Institute for Behavioral Medicine" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Institute for Behavioral Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Institute for Behavioral Medicine, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Institute for Behavioral Medicine, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".